Adherence to drugs that prevent cardiovascular disease: Meta-analysis on 376,162 patients

American Journal of Medicine

Volumn 125, Issue 9, 2012, Pages 882-887.e1

  Naderi, Sayed H ^a   Bestwick, Jonathan P ^a   Wald, David S ^a  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

Adherence; Cardiovascular disease; Prevention

Indexed keywords

ACETYLSALICYLIC ACID; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CARDIOVASCULAR AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; THIAZIDE DIURETIC AGENT;

ADULT; AGE; AGED; ARTICLE; CONFIDENCE INTERVAL; CONTROLLED STUDY; FEMALE; HEALTH INSURANCE; HEART INFARCTION; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; META ANALYSIS; PATIENT COMPLIANCE; PRESCRIPTION; PRIMARY PREVENTION; PRIORITY JOURNAL; REGRESSION ANALYSIS; SECONDARY PREVENTION; STATISTICAL SIGNIFICANCE; TREATMENT DURATION;

EID: 84865677850     PISSN: 00029343     EISSN: 15557162     Source Type: Journal    
DOI: 10.1016/j.amjmed.2011.12.013     Document Type: Article

References (48)

1. World Health Organization The top 10 causes of death http://www.who.int/ mediacentre/factsheets/fs310/en/index.html Accessed February 2, 2012
2. N.J. Wald, M.R. Law A strategy to reduce cardiovascular disease by more than 80% BMJ 326 2003 1419 1423
3. M.R. Law, N.J. Wald, J.K. Morris, R.E. Jordan Value of low dose combination treatment with blood pressure lowering drugs: analysis of 354 randomised trials BMJ 326 2003 1427 1431
4. M.R. Law, N.J. Wald, A.R. Rudnicka Quantifying effect of statins on low density lipoprotein cholesterol, ischaemic heart disease and stroke: systematic review and meta-analysis BMJ 326 2003 1423 1427
5. Medicines Adherence: Involving Patients in Decisions About Prescribed Medicines and Supporting Adherence Full Guideline January 2009 2009 National Collaborating Centre for Primary Care, The Royal College of General Practitioners Hyde Park, London
6. J.F. Steiner, A.V. Prochazka The assessment of refill compliance using pharmacy records: methods, validity and applications J Clin Epidemiol 50 1997 619 625
7. J.M. Kramer, B. Hammill, K.J. Anstrom National evaluation of adherence to beta-blocker therapy for 1 year after acute myocardial infarction in patients with commercial health insurance Am Heart J 152 2006 454e.1-454e.8
8. J.S. Benner, R.J. Glynn, H. Mogun, P.J. Neumann, M.C. Weinstein, J. Avorn Long-term persistence in use of statin therapy in elderly patients JAMA 288 2002 455 461
9. J.N. Rasmussen, A. Chong, D.A. Alter Relationship between adherence to evidence based pharmacotherapy and long-term mortality after acute myocardial infarction JAMA 297 2007 177 186
10. Expat Focus http://www.expatfocus.com/expatriate-netherlands-holland- healthcare-medical Accessed February 2, 2012
11. Socialist Health Association http://www.sochealth.co.uk/news/ prescriptions.htm Accessed February 2, 2012
12. L. Degli Esposti, G. Valpiani, S. Saragoni, A. Capone A retrospective, population based analysis on persistence with antihypertensive drug therapy in primary care practice in Italy Clin Ther 24 2002 1347 1357
13. B.L.G. Van Wijk, O.H. Klungel, E.R. Heerdink, A. de Boer Rate and determinants of 10 year persistence with antihypertensive drugs J Hypertens 23 2005 2101 2107
14. L.A. Simons, M. Ortiz, G. Calcino Persistence with antihypertensive medication: Australia wide experience, 2004-2006 Med J Aust 188 2008 224 227
15. M.A. Marentette, W.C. Gerth, D.K. Billings, K.B. Zarnke Antihypertensive persistence and drug class Can J Cardiol 18 2002 649 656
16. N.S. Breekveldt-Postma, F.J.A. Penning-van Beest, S.J. Siiskoven The effect of discontinuation of antihypertensives on the risk of acute myocardial infarction and stroke Curr Med Res Opin 24 2008 121 127
17. S. Perreault, D. Lamarre, L. Blais Persistence with treatment in newly treated middle-aged patients with essential hypertension Ann Pharmacother 39 2005 1401 1408
18. B.S. Bloom Continuation of initial antihypertensive medication after 1 year of therapy Clin Ther 20 1998 671 681
19. W.J. Elliott, C.A. Plauschinat, G.H. Skrepnek, D. Gause Persistence, adherence, and risk of discontinuation associated with commonly prescribed antihypertensive drug monotherapies J Am Board Fam Med 20 2007 72 80
20. J. Avorn, J. Monette, A. Lacour Persistence of use of lipid lowering medications: a cross national study JAMA 279 1998 1458 1462
21. R.W. Grant, K.M. O'Leary, J.B. Weilburg, D.E. Singer, J.B. Meigs Impact of concurrent medication use on statin adherence and refill persistence Arch Intern Med 164 2004 2343 2348
22. L. Wei, R. Flynn, G.D. Murray, T.M. MacDonal Use and adherence to beta-blockers for secondary prevention of myocardial infarction: who is not getting the treatment? Pharmacoepidemiol Drug Saf 13 2004 761 766
23. B. Kopjar, A.E.B. Sales, S. Pineros, H. Sun, Y.F. Li, A.N. Hedeen Adherence with statin therapy in secondary prevention of coronary heart disease in veterans administration male population Am J Cardiol 92 2003 1106 1108
24. E. Simpson, C. Beck, H. Richard Drug prescriptions after acute myocardial infarction: dosage, compliance and persistence Am Heart J 145 2003 438 444
25. E.E. Roughead, A.I. Vitry, A.K. Preiss Assessing overall duration of cardiovascular medicines in veterans with established cardiovascular disease Eur J Cardiovasc Prev Rehabil 17 2010 71 76
26. D.F. Blackburn, R.T. Dobson, J.L. Blackburn Adherence to statins, beta blockers and angiotensin converting enzyme inhibitors following a first cardiovascular event: a retrospective cohort study Can J Cardiol 21 2005 485 488
27. G.H. Gislason, J.N. Rasmussen, S.Z. Abildstrom Long-term compliance with beta-blockers, angiotensin-converting enzyme inhibitors and statins after acute myocardial infarction Eur Heart J 27 2006 1153 1158
28. P.M. Ho, D.J. Magid, S.M. Shetterly Medication nonadherence is associated with a broad range of adverse outcomes in patients with coronary artery disease Am Heart J 155 2008 772 779
29. R. DerSimonian, N. Laird Meta-analysis in clinical trials Control Clin Trials 7 1986 177 188
30. StataCorp Stata Statistical Software: Release 10 2007 StataCorp LP College Station, TX
31. P.M. Ho, C.L. Bryson, J.S. Rumsfeld Medication adherence its importance in cardiovascular outcomes Circulation 119 2009 3028 3035
32. Patient compliance with statins www.medicine.ox.ac.uk/bandolier/booth/ cardiac/patcomp.html Accessed February 2, 2012
33. R.A. Hamilton, L.L. Briceland Use of prescription-refill records to assess patient compliance Am J Hosp Pharmacol 49 1992 1691 1696
34. R. Tamblyn, G. Lavoie, L. Petrella The use of prescription claims databases in pharmacoepidemiological research: the accuracy and comprehensiveness of the prescription claims databases in Quebec J Clin Epidemiol 48 1995 999 1009
35. L. Osterberg, T. Blaschke Adherence to medication N Engl J Med 353 2005 487 497
36. A.K. Gehi, S. Ali, B. Na, M.A. Whooley Self-reported medication adherence and cardiovascular events in patients with stable coronary heart disease The Heart and Soul Study Arch Intern Med 167 2007 1798 1803
37. D.S. Wald, G. Morton, K. Walker Long-term continuation on cardiovascular drug treatment in patients with coronary heart disease Ann Pharmacother 41 2007 1644 1647
38. C. Melloni, K.P. Alexander, F. Ou Predictors of early discontinuation of evidence based medicine after acute coronary syndrome Am J Cardiol 104 2009 175 181
39. K.A. Eagle, E. Kline-Rogers, S.G. Goodman Adherence to evidence-based therapies after discharge for acute coronary syndromes: an ongoing prospective, observational study Am J Med 117 2004 73 81
40. A. Sud, E.M. Kline-Rogers, K.A. Eagle Adherence to medications by patients after acute coronary syndromes Ann Pharmacother 39 2005 1792 1797
41. L.K. Newby, N.M.A. La Poiante, A.Y. Chen Long-term adherence to evidence based secondary prevention therapies in coronary artery disease Circulation 113 2006 203 212
42. J. Amar, J. Ferrieres, J.P. Cambou Persistence of combination of evidence based medical therapy in patients with acute coronary syndromes Arch Cardiovasc Dis 101 2008 301 306
43. V.L. Roger, A.S. Go, D.M. LIoyd-Jones Heart disease and stroke statistics - 2011 update: a report from the American Heart Association Circulation 123 2011 e18 e209
44. R.B. Haynes, H. McDonald, A.X. Garg, P. Montague Interventions for helping patients follow prescriptions for medications Cochrane Database Syst Rev 2 2002 CD000011
45. J.D. Piette Interactive voice response systems in the diagnosis and management of chronic disease Am J Manage Care 6 2000 817 827
46. M.D. Murray, J. Young, S. Hoke Pharmacist intervention to improve medication adherence in heart failure: a randomised trial Ann Intern Med 146 2007 714 725
47. A.W. Armstrong, A.J. Watson, M. Makredes Text-message reminders to improve sunscreen use: a randomized, controlled study using electronic monitoring Arch Dermatol 145 2009 1230 1236
48. Free C, Knight R, Robertson S, et al. Smoking cessation support delivered via mobile phone text messaging (txt2stop): a single blind, randomised trial. Lancet. 378;9785:49-55.